This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   Jun. 18, 2013

 



Myriad gene patent ruling triggers race for cancer tests
Bloomberg
Companies and a university are moving to offer cheaper and broader genetic testing for breast cancer risk to a growing group of women, following a U.S. Supreme Court ruling that ended Myriad Genetics Inc.'s monopoly over DNA that vastly raises odds for the disease. Within hours of the decision, the University of Washington and Ambry Genetics, a closely held company in Aliso Viejo, Calif., said they would immediately offer expanded testing that included the BRCA1 and BRCA2 genes, which Myriad has had under patent since the late 1990s.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




FDA warns of cyber threats to medical devices
WNYW-TV
The FDA is recommending beefed up security on medical devices to reduce the risk that devices are compromised via a cyber threat. Among the issues raised in a Department of Homeland Security warning was that a security researcher demonstrated how an outside actor can shut off or alter the settings of an insulin pump without the user's knowledge.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Once-a-day pill prevents HIV in drug users
NBC News
A once-a-day pill can protect people who inject drugs such as heroin from the AIDS virus, lowering their risk by nearly 50 percent, researchers reported. The findings show that even people at the highest risk of being infected with the virus can protect themselves — and thus protect others.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
 


Could urine test replace the mammogram?
Prevention
Yinfa Ma, Ph.D., Curators' Teaching Professor of chemistry at Missouri University of Science and Technology, has developed a new screening method that uses a urinalysis to diagnose breast cancer — and determine its severity — even before it can be detected with a mammogram. The clinical trial is ongoing at Mercy Breast Center in Springfield, Mo., and the researchers are actively seeking participants.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New SARS-like virus: How big is the threat?
Forbes
Ten years after a severe viral illness emerged in southeast China, no pandemic has emerged, perhaps due to a vigorous public health response, but probably also due to the biology of the virus. Like many similar viruses, its spread was facilitated by crowded living conditions and by the ease of international travel. Its demise is less well understood.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE

Sponsored Content


How to discover an antibiotic: A historian's guide
The Guardian
Given our pressing need for new antibiotics, or a whole new class of antibiotic-like drugs, perhaps we ought to try learning lessons from the history of penicillin.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Endoscopes still dirty after manual cleaning
Medscape Medical News
In a study that measured the cleanliness of endoscopes used at five hospitals across the United States, 3 of 20 flexible gastrointestinal endoscopes used for screening were found to harbor unacceptable levels of bacteria. The finding was a surprise, lead author Marco Bommarito, Ph.D., from the infection prevention division at 3M, in St. Paul, Minn., said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword LAB EQUIPMENT


  FEATURED COMPANIES
JoinYour Peers

Many employers now require certification because they know that individuals who are certified are committed to their profession and to quality patient care. Learn how we can help!

www.americanmedtech.org
Overseas Opportunities: Medical Laboratory Scientists
U.S. Department of State: Live and work abroad, administering tests and procedures that aid in the medical care of U.S. diplomats and their families. careers.state.gov/MLS13


Depression tied to infections, autoimmune disease
MedPage Today
Autoimmune disease and severe infections may increase risk of developing depression and other mood disorders, a population-based study suggested. Any contact with a hospital for autoimmune disease was associated with an independent and significant 45 percent higher risk of a subsequent mood disorder diagnosis, Michael Eriksen Benros, M.D., of Denmark's Aarhus University, and colleagues reported online in JAMA Psychiatry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Sensor that detects melanoma via odor developed
Nature World News
Researchers have found a way to detect cancerous cells from healthy skin cells via their odor. The study findings are expected to help doctors diagnose skin cancer early and provide treatments for patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  POWERVAR - Reliable Power Since 1986

POWERVAR offers an in-depth product portfolio of real solutions and real protection for the technology your business relies on to keep your operation running smoothly.
 


Retractable needle reduces stick injuries
Medscape Medical News
Using a retractable steel needle instead of a resheathable needle decreased the rate of accidental needle-stick injuries by almost half among nurses and phlebotomists at a large hospital in New York City. "We were getting approximately 50 needle sticks a year in our institution because of the cumbersome nature of the device we were using to draw blood," Alexandra Derevnuk, RN, coordinator of infection control and blood and body fluid exposure at the Mount Sinai Medical Center in New York City, said. "When we switched, this went down to 25 needle sticks per year."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Michael Douglas' throat cancer comments thrust HPV discussion to fore (CBS News)
New hepatitis C diagnosis and treatment (By Rosemary Sparacio)
Battle brews over FDA regulation of laboratory-developed tests (Reuters via Thomson Reuters)
More breast-feeding could lower breast cancer rates by thousands (CBS News)

Don't be left behind. Click here to see what else you missed.


Stem cell discovery could help regrow fingers
LiveScience via Discovery
Mammals can regenerate the very tips of their fingers and toes after amputation, and now new research shows how stem cells in the nail play a role in that process. A study in mice, detailed online in the journal Nature, reveals the chemical signal that triggers stem cells to develop into new nail tissue, and also attracts nerves that promote nail and bone regeneration.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
MOST POPULAR ARTICLE
TRENDING ARTICLE
Myriad gene patent ruling triggers race for cancer tests
Bloomberg
Companies and a university are moving to offer cheaper and broader genetic testing for breast cancer risk to a growing group of women, following a U.S. Supreme Court ruling that ended Myriad Genetics Inc.'s monopoly over DNA that vastly raises odds for the disease.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Michael Douglas' throat cancer comments thrust HPV discussion to fore
CBS News
Michael Douglas is drawing worldwide attention. In an interview, he appeared to blame his throat cancer on oral sex and HPV, a sexually transmitted disease. One expert celebrated Douglas' openness about the subject, but questioned his comment's accuracy.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
In clinical trial, scientists hope to train immune system to attack cancer
Stanford University Medical Center via Medical Xpress
Training our immune systems to fight cancer is an appealing prospect. But the process is a bit like learning to spot a single traitor in a stadium full of innocent bystanders.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


Shape of nanoparticles can enhance drug targeting
Sanford-Burnham Medical Research Institute via Laboratory Equipment
Conventional treatments for diseases such as cancer can carry harmful side effects — and the primary reason is that such treatments are not targeted specifically to the cells of the body where they're needed. What if drugs for cancer, cardiovascular disease and other diseases can be targeted specifically and only to cells that need the medicine, and leave normal tissues untouched?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Build A Powerful Online Presence
iPage makes it easy and affordable to create a powerful website for your business – no experience necessary. Add to that a 24x7 support team and tons of free marketing tools, and you’ve got the recipe for online success! You can drive more traffic and get more customers than ever before.
 


VU study identifies new mechanism for cancer development
Vanderbilt University via HealthCanal.com
Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom. Bhuminder Singh, Ph.D., is first author of a paper describing how "mistrafficking" of a ligand, a protein that binds to the EGF receptor, can "transform" epithelial cells into a particularly vicious tumor in mice.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

June 18, 2013
June 11, 2013
June 4, 2013
May 29, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063